Contract Signed For OEM Supply Of Blood Coagulation Analyzers And Dedicated Reagents To The European And South American Markets

SEKISUI MEDICAL CO., LTD. (President: Mutsumi Fukuda, hereinafter Sekisui Medical), a 100% subsidiary of SEKISUI CHEMICAL, CO., LTD. (President: Naofumi Negishi, hereinafter Sekisui Chemical), has signed an OEM agreement to supply blood coagulation analyzers and dedicated reagents to Nihon Kohden Corporation (President & COO: Fumio Suzuki, hereinafter Nihon Kohden) in order to expand its overseas business in the field of blood coagulation analysis. 1.

Background
Sekisui Medical entered the field of blood coagulation analysis reagents in 1979 with “Testzym”, a series of reagents based on the synthetic substrate method. Thanks to its product lineup of Nanopia and Coagpia brands, it now holds the largest share of domestic sales in the field (internal estimation).
 
Sekisui Medical released the blood coagulation analyzer “Coapresta 2000” in March 2007 and began its medical instrument business where instruments and reagents are combined. Over 200 units of “Coapresta 2000” have been installed mainly in large hospitals such as university hospitals, and it holds the top share for annual domestic deliveries of instruments in its class (internal estimation). Moreover, in April 2009 Sekisui Chemical acquired the US-based American Diagnostica Inc. (ADI), a company that has proven itself in the field of blood coagulation analysis reagents. Joint development of blood coagulation analysis reagents with ADI will create a structure to further enhance Sekisui Medical’s product lineup and is an example of the efforts being made to expand the instruments business in the field of blood coagulation analysis.
 
With this agreement with Nihon Kohden, Sekisui Medical is going to expand the overseas business of blood coagulation analysis instruments and reagents through Nihon Kohden’s global sales and service network.
 
Read more here.

600450 Contract Signed For OEM Supply Of Blood Coagulation Analyzers And Dedicated Reagents To The European And South American Markets glassonweb.com
Date: 6 August 2010
Source: Sekisuichemical.com

See more news about:

See more from these topics:

Others also read

Eastman Performance Films, LLC, will return to the 2018 International Window Film Conference and Tint-Off™ (WFCT) this fall in San Antonio, Texas, as a Diamond-Plus sponsor. The company will once again feature both the LLumar® and SunTek® brands.
Only one annual event shines the spotlight on automotive, architectural, paint protection, security and decorative films as well as wraps—the International Window Film Conference and Tint-Off™.
Throughout the globe, SEKISUI S-Lec develops and sells film for laminated glass used in cars and buildings. 
Not one to rest on its laurels, SafeGuard Glass and Glazing has just completed a further stage of investment, despite completing a £1.5m investment into manufacturing capabilities and premises’ move in 2016.
Launched in September 2017, the Solar Smart Mobility project aims to develop and industrialise a total new production area in supple, transparent photovoltaic glazing adapted to transport applications.
3M worked with interior designers and contractors over a number of years to develop a range of high quality films that mimic the aesthetics of natural and synthetic materials at a fraction of the cost – 3M Fasara Glass Finishes.

From industry

Da Vincilaan 1,
1935 Zaventem
Belgium

Schaliënhoevedreef 20-D,
2800 Mechelen
Belgium

NEWS RELATED PRODUCTS

Vitro Architectural Glass (Formerly PPG Glass)

Add new comment